ArticleAmerican heart journal plus : cardiology research and practice2023

Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial.

Julie Hempel Larsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.